These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 25645763)

  • 1. Economic analysis of the treatment of end-stage renal disease treatment: living-donor kidney transplantation versus hemodialysis.
    Sánchez-Escuredo A; Alsina A; Diekmann F; Revuelta I; Esforzado N; Ricart MJ; Cofán F; Torregrosa JV; Campistol JM; Oppenheimer F; Fernandez E
    Transplant Proc; 2015; 47(1):30-3. PubMed ID: 25645763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cost-effectiveness analysis of treatment for end-stage renal disease].
    Asgeirsdóttir TL; Asmundsdóttir G; Heimisdóttir M; Jónsson E; Pálsson R
    Laeknabladid; 2009 Nov; 95(11):747-53. PubMed ID: 19996463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment strategies for insulin-dependent diabetics with ESRD: a cost-effectiveness decision analysis model.
    Douzdjian V; Ferrara D; Silvestri G
    Am J Kidney Dis; 1998 May; 31(5):794-802. PubMed ID: 9590189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal transplantation vs hemodialysis: cost-effectiveness analysis.
    Perović S; Janković S
    Vojnosanit Pregl; 2009 Aug; 66(8):639-44. PubMed ID: 19780419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [REIN Report 2011--summary].
    Couchoud C; Lassalle M; Jacquelinet C
    Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variations in living donor graft rates by dialysis clinic: effect on outcome and cost of chronic renal failure therapy.
    Baltzan MA; Ahmed S; Baltzan RB; Marshall RP; Thoma EL; Nicol MF
    Clin Nephrol; 1997 Jun; 47(6):351-5. PubMed ID: 9202863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cost-effectiveness of interventions for end-stage renal disease].
    Arredondo A; Rangel R; de Icaza E
    Rev Saude Publica; 1998 Dec; 32(6):556-65. PubMed ID: 10349148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness analysis of the treatment of end-stage renal disease in Brazil.
    Sesso R; Eisenberg JM; Stabile C; Draibe S; Ajzen H; Ramos O
    Int J Technol Assess Health Care; 1990; 6(1):107-14. PubMed ID: 2113888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cost utility of renal transplant vs. hemodialysis in the treatment of end stage chronic kidney failure in a Peruvian hospital].
    Loza-Concha RE; Quispe AM
    Rev Peru Med Exp Salud Publica; 2011; 28(3):432-9. PubMed ID: 22086622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic burden and cost-utility analysis of three renal replacement therapies in ESRD patients from Yunnan Province, China.
    Wu H; Li Q; Cai Y; Zhang J; Cui W; Zhou Z
    Int Urol Nephrol; 2020 Mar; 52(3):573-579. PubMed ID: 32009220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of haemodialysis and peritoneal dialysis for patients with end-stage renal disease in Singapore.
    Yang F; Lau T; Luo N
    Nephrology (Carlton); 2016 Aug; 21(8):669-77. PubMed ID: 26566750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should patients remain on intensive hemodialysis rather than choosing to receive a kidney transplant?
    McFarlane PA
    Semin Dial; 2010; 23(5):516-9. PubMed ID: 21039877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The cost of dialysis and kidney transplantation in France in 2007, impact of an increase of peritoneal dialysis and transplantation].
    Blotière PO; Tuppin P; Weill A; Ricordeau P; Allemand H
    Nephrol Ther; 2010 Jul; 6(4):240-7. PubMed ID: 20554257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic evaluation of palliative management versus peritoneal dialysis and hemodialysis for end-stage renal disease: evidence for coverage decisions in Thailand.
    Teerawattananon Y; Mugford M; Tangcharoensathien V
    Value Health; 2007; 10(1):61-72. PubMed ID: 17261117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Live donor kidney transplantation. Situation analysis and roadmap.
    de la Oliva Valentín M; Hernández D; Crespo M; Mahillo B; Beneyto I; Martínez I; Kanter J; Calderari E; Gil-Vernet S; Sánchez S; Agüera ML; Bernal G; de Santiago C; Díaz-Corte C; Díaz C; Espinosa L; Facundo C; Fernández-Lucas M; Ferreiro T; García-Erauzkin G; García-Alvarez T; Fraile P; González-Rinne A; González-Soriano MJ; González E; Gutiérrez-Dalmau A; Jiménez C; Lauzurica R; Lorenzo I; Martín-Moreno PL; Moreso F; de Gracia MC; Pérez-Flores I; Ramos-Verde A; Revuelta I; Rodríguez-Ferrero ML; Ruiz JC; Sánchez-Sobrino B; Domínguez-Gil B
    Nefrologia (Engl Ed); 2022; 42(1):85-93. PubMed ID: 36153903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health economic evaluations: the special case of end-stage renal disease treatment.
    Winkelmayer WC; Weinstein MC; Mittleman MA; Glynn RJ; Pliskin JS
    Med Decis Making; 2002; 22(5):417-30. PubMed ID: 12365484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dialysis versus renal transplantation; a comparative study on medical cost and quality of life in patients with chronic renal failure].
    Tajima A; Ueda D; Hirai M; Morinaga S; Sudoko H; Yamaguchi Y; Mitsuhashi T; Nakano M; Kanbayashi T; Ushiyama T
    Hinyokika Kiyo; 1987 Oct; 33(10):1536-41. PubMed ID: 3128069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct medical costs of end-stage kidney disease and renal replacement therapy: a cohort study in Guangzhou City, southern China.
    Zhang H; Zhang C; Zhu S; Ye H; Zhang D
    BMC Health Serv Res; 2020 Feb; 20(1):122. PubMed ID: 32059726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Filtering for the best policy: An economic evaluation of policy options for kidney replacement coverage in the Philippines.
    Bayani DBS; Almirol BJQ; Uy GDC; Taneo MJS; Danguilan RS; Arakama MI; Lamban AB; de Leon D; Pamugas GEP; Luz AC; Teerawatananon Y
    Nephrology (Carlton); 2021 Feb; 26(2):170-177. PubMed ID: 33207027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reassessing Preemptive Kidney Transplantation in the United States: Are We Making Progress?
    Jay CL; Dean PG; Helmick RA; Stegall MD
    Transplantation; 2016 May; 100(5):1120-7. PubMed ID: 26479285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.